CClinicalTrials.gg
Status unknownNCT05474898Updated Sep 27, 2022

IONTOPHORESIS Versus Ultrasound in Mechanical Neck Pain

An interventional study of Magnesium Sulphate Iontophoresis +conventional therapy and High- Power Pain Threshold Ultrasound +conventional therapy in Trigger Point Pain, Myofascial, sponsored by Cairo University. Status unknown at 1 site in Egypt. Open to participants aged 19 Years to 23 Years. Per ClinicalTrials.gov, last updated 2022-09-27.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Sep 2022), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
19 Years to 23 Years
Sex
All
01

Study summary

to investigate the effects of Magnesium Sulphate Iontophoresis versus High Power Pain Threshold Ultrasound on pain, function and range of motion on active MTrPs found in the upper trapezius.

Read the detailed description

Myofascial pain syndrome (MPS) is a musculoskeletal chronic pain disorder that affects the majority of pain population and characterized by the presence of trigger points. MPS is usually associated with tenderness, spasm, movement limitation and referred pain .

Myofascial trigger points (MTrPs) are hyperirritable taut fibers of skeletal muscle. The taut fibers within the muscle create palpable nodules that may cause local pain, and refer pain elsewhere with soft tissue examination .

02

Conditions studied

  • Trigger Point Pain, Myofascial
03

In context

Myofascial Pain Syndromes

1,136 studies on the registry are indexed under Myofascial Pain Syndromes; 137 are open to participants now.

This study's planned enrollment of 90 is above the median of 60 across 931 interventional studies indexed under Myofascial Pain Syndromes.

Browse Myofascial Pain Syndromes studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 23 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Subjects, with age ranged from 19-23 years (Forman et al, 2014) from both genders. The subjects had active MTrPs in the upper fibers of trapezius muscle.

Exclusion criteria

Exclusion Criteria:

    • History of whiplash injury.

      • History of cervical spine surgery.
      • Cervical radiculopathy or myelopathy.
      • Having undergone physical therapy within the past three months before the study.
      • Non- rheumatologic diseases as multiple sclerosis, thyroid dysfunction and chronic infection.
      • Rheumatologic condition as poly-articular osteoarthritis, rheumatoid arthritis and advanced cervical spine degenerative diseases.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
90 participants (estimated)

Study arms

  • Experimental
    Group (A)

    Other: Magnesium Sulphate Iontophoresis +conventional therapy · Other: conventional theapy

  • Experimental
    Group (B)

    Other: High- Power Pain Threshold Ultrasound +conventional therapy · Other: conventional theapy

  • Other
    Group (c)

    Other: conventional theapy

Interventions

  • OtherMagnesium Sulphate Iontophoresis +conventional therapy

    will receive Mgso4 Iontophoresis in addition to conventional therapy twice a week/4 weeks

  • OtherHigh- Power Pain Threshold Ultrasound +conventional therapy

    will receive HPPT-US on the upper trapezius in addition to conventional therapy twice a week/4 weeks

  • Otherconventional theapy

    will receive postural correction exercise-stretching and strengthening twice a week/4weeks

06

What researchers measure

Primary outcomes

  1. pain intensity

    The scale that will be used the VAS ;each subject will instructed to put point on line from no pain to tolerable pain

    Time frame: up to four weeks

Secondary outcomes

  1. Pain pressure threshold (PPT)

    Pain pressure threshold (PPT) is used to measure deep muscular tissue sensitivity by Algometer.

    Time frame: up to four weeks

  2. neck disability

    will be measured by Arabic neck disability index

    Time frame: up to four weeks

  3. range of motion

    will be measured by myrin gravity reference goniometer

    Time frame: up to four weeks

07

Study locations

1 of 1 sites recruiting
  • Faculty of Physical Therapy Cairo University
    Cairo, Egypt
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 27, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05474898
Lead sponsor
Cairo University
Responsible party
Hend Hamdy (lecturer of pt for basic science department, Cairo University) — Principal investigator
First posted
Jul 26, 2022
Start date
Aug 8, 2022
Primary completion
Oct 1, 2022 (estimated)
Completion
Nov 15, 2022 (estimated)
Last update
Sep 27, 2022

Study contacts

Hend Hamdy, PHD
Contact
hendhamdy110@yahoo.com
01024420121

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion